» Articles » PMID: 39110788

Epigenetic Reprogramming Driving Successful and Failed Repair in Acute Kidney Injury

Overview
Journal Sci Adv
Specialties Biology
Science
Date 2024 Aug 7
PMID 39110788
Authors
Affiliations
Soon will be listed here.
Abstract

Acute kidney injury (AKI) causes epithelial damage followed by subsequent repair. While successful repair restores kidney function, this process is often incomplete and can lead to chronic kidney disease (CKD) in a process called failed repair. To better understand the epigenetic reprogramming driving this AKI-to-CKD transition, we generated a single-nucleus multiomic atlas for the full mouse AKI time course, consisting of ~280,000 single-nucleus transcriptomes and epigenomes. We reveal cell-specific dynamic alterations in gene regulatory landscapes reflecting, especially, activation of proinflammatory pathways. We further generated single-nucleus multiomic data from four human AKI samples including validation by genome-wide identification of nuclear factor κB binding sites. A regularized regression analysis identifies key regulators involved in both successful and failed repair cell fate, identifying the transcription factor CREB5 as a regulator of both successful and failed tubular repair that also drives proximal tubular cell proliferation after injury. Our interspecies multiomic approach provides a foundation to comprehensively understand cell states in AKI.

Citing Articles

EZH2-mediated macrophage-to-myofibroblast transition contributes to calcium oxalate crystal-induced kidney fibrosis.

Xia Y, Ye Z, Li B, Yan X, Yuan T, Li L Commun Biol. 2025; 8(1):286.

PMID: 39987296 PMC: 11846861. DOI: 10.1038/s42003-025-07735-3.


Multiomics profiling of mouse polycystic kidney disease progression at a single-cell resolution.

Muto Y, Yoshimura Y, Wu H, Chang-Panesso M, Ledru N, Woodward O Proc Natl Acad Sci U S A. 2024; 121(43):e2410830121.

PMID: 39405347 PMC: 11513963. DOI: 10.1073/pnas.2410830121.


The Kidney Precision Medicine Project and Single-Cell Biology of the Injured Proximal Tubule.

Janosevic D, De Luca T, Eadon M Am J Pathol. 2024; 195(1):7-22.

PMID: 39332674 PMC: 11686451. DOI: 10.1016/j.ajpath.2024.09.006.


Multi-omics profiling of mouse polycystic kidney disease progression at a single cell resolution.

Muto Y, Yoshimura Y, Wu H, Chang-Panesso M, Ledru N, Woodward O bioRxiv. 2024; .

PMID: 38854144 PMC: 11160654. DOI: 10.1101/2024.05.27.595830.

References
1.
Jaiswal S, Chao M, Majeti R, Weissman I . Macrophages as mediators of tumor immunosurveillance. Trends Immunol. 2010; 31(6):212-9. PMC: 3646798. DOI: 10.1016/j.it.2010.04.001. View

2.
Barrera-Chimal J, Estrela G, Lechner S, Giraud S, El Moghrabi S, Kaaki S . The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling. Kidney Int. 2018; 93(6):1344-1355. DOI: 10.1016/j.kint.2017.12.016. View

3.
Wilson P, Muto Y, Wu H, Karihaloo A, Waikar S, Humphreys B . Multimodal single cell sequencing implicates chromatin accessibility and genetic background in diabetic kidney disease progression. Nat Commun. 2022; 13(1):5253. PMC: 9448792. DOI: 10.1038/s41467-022-32972-z. View

4.
Kent W, Sugnet C, Furey T, Roskin K, Pringle T, Zahler A . The human genome browser at UCSC. Genome Res. 2002; 12(6):996-1006. PMC: 186604. DOI: 10.1101/gr.229102. View

5.
Ushach I, Zlotnik A . Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage. J Leukoc Biol. 2016; 100(3):481-9. PMC: 4982611. DOI: 10.1189/jlb.3RU0316-144R. View